Your position:m.limatoxi.com>>EN>>EN>>Pharmaceutical News>>Garden biology science technology co., ltd in the first half of 2022, the operating income of vitamin D3 series products was 233 million yuan, a year-on-year decrease of 10.13%.>> article
Garden biology science technology co., ltd in the first half of 2022, the operating income of vitamin D3 series products was 233 million yuan, a year-on-year decrease of 10.13%.
Editor:xuezhe Clicks:0Date:2022-8-18 11:46:23
Keyword:vitamin D3
Healthoo Information:
Garden biology science technology co., ltd in the first half of 2022, the operating income of vitamin D3 series products was 233 million yuan, a year-on-year decrease of 10.13%.
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • 2022 FIC Guangzhou Exhibition is approaching, the products of domestic...
  • Vitamin K3 (feed) reference prices
  • Vitamin B6 (food) reference price
  • Vitamin B6 (feed) reference price
  • Vitamin B12 (Cyanocobalamin) reference price
  • Vitamin B12 (feed ) reference price
  • Vitamin B1 (hydrochloride)reference price
  • Vitamin B1 (nitrate)reference price
  • Vitamin D3 (feed) reference price
  • 25-hydroxyvitamin D3(feed) reference price
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map